CG
PGEN icon

Cutler Group’s Precigen PGEN Stock Holding History

Cutler Group’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-500
Closed -$1K – 4486
2022
Q4 		$1K Hold
500
– – ﹤0.01% 4114
2022
Q3 		$1K Hold
500
– – ﹤0.01% 4639
2022
Q2 		$1K Hold
500
– – ﹤0.01% 4684
2022
Q1 		$1K Sell
500
-200
-29% -$487 ﹤0.01% 5043
2021
Q4 		$1K Buy
+700
New +$3.01K ﹤0.01% 5092
2020
Q1 		– Sell
-14,900
Closed -$69K – 4483
2019
Q4 		$69K Hold
14,900
– – ﹤0.01% 1410
2019
Q3 		$64K Sell
14,900
-100
-0.7% -$679 0.01% 1362
2019
Q2 		$56K Buy
15,000
+100
+0.7% +$538 0.01% 1473
2019
Q1 		$78K Sell
14,900
-11,700
-44% -$81.1K 0.01% 1146
2018
Q4 		$115K Buy
26,600
+16,300
+158% +$183K 0.01% 942
2018
Q3 		$4K Buy
10,300
+900
+10% +$13.4K ﹤0.01% 3198
2018
Q2 		$3K Sell
9,400
-2,800
-23% -$47.3K ﹤0.01% 3402
2018
Q1 		$9K Sell
12,200
-3,800
-24% -$54.3K ﹤0.01% 2873
2017
Q4 		$72K Buy
16,000
+7,600
+90% +$113K ﹤0.01% 1604
2017
Q3 		$29K Buy
8,400
+4,000
+91% +$82.3K ﹤0.01% 2775
2017
Q2 		$11K Sell
4,400
-25,900
-85% -$568K ﹤0.01% 4080
2017
Q1 		$47K Sell
30,300
-15,206
-33% -$339K ﹤0.01% 2474
2016
Q4 		$664K Sell
45,506
-706
-2% -$19.7K 0.02% 564
2016
Q3 		$620K Sell
46,212
-12,310
-21% -$326K 0.03% 514
2016
Q2 		$774K Sell
58,522
-65,282
-53% -$1.85M 0.04% 377
2016
Q1 		$639K Buy
123,804
+72,042
+139% +$2.27M 0.04% 426
2015
Q4 		$733K Buy
+51,762
New +$1.74M 0.04% 447

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $2.74B AUM 43.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cutler Group's PGEN Position: Q1 2024 in Review

Cutler Group reduced its Precigen (PGEN) stake by 8.3% in Q1 2024, selling an estimated $718 and leaving 5,500 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #1446.

Cutler Group first reported a position in PGEN in Q4 2015 and has held it in 34 quarters since. The position peaked at $1.75M in Q3 2016. 130 funds tracked by Wall St. Rank hold PGEN as of Q1 2024.

  • Cutler Group held 5,500 shares of Precigen worth $7K as of Q1 2024.
  • Cutler Group sold 500 Precigen shares in Q1 2024, an estimated $718.
  • Precigen made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1446 holding.
  • Cutler Group first reported a position in Precigen in Q4 2015 and has held it in 34 quarters since.
  • Cutler Group's Precigen position peaked at $1.75M in Q3 2016.
  • 130 funds tracked by Wall St. Rank held Precigen as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.